Accendra Health, Inc.ACHNYSE
Loading
| Metric | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 |
|---|---|---|---|---|---|
| Revenue Growth | +1.50% | +0.74% | +3.26% | +1.52% | -73.70% |
| Gross Profit Growth | +1.73% | -1.78% | +2.71% | -2.89% | -49.93% |
| EBITDA Growth | -225.48% | -32.68% | -99.43% | -2.22% | +0.00% |
| Operating Income Growth | -536.46% | -98.72% | -334.66% | -14.83% | +0.00% |
| Net Income Growth | -1765.07% | +0.00% | +0.00% | +0.00% | +0.00% |
| EPS Growth | -1769.57% | +0.00% | +0.00% | +0.00% | +0.00% |
| EPS Diluted Growth | -1769.57% | +0.00% | +0.00% | +0.00% | +0.00% |
| Weighted Average Shares Growth | +1.16% | +1.25% | +0.27% | +0.26% | -0.61% |
| Weighted Average Shares Diluted Growth | -0.78% | +1.25% | +0.27% | +0.26% | -0.61% |
| Dividends per Share Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Operating Cash Flow Growth | -36.47% | +0.00% | -67.62% | -731.78% | -3.96% |
| Free Cash Flow Growth | -85.27% | +0.00% | -143.03% | +0.00% | +574.09% |
| Receivables Growth | +15.38% | -13.39% | -70.44% | -69.36% | -86.11% |
| Inventory Growth | +1.92% | +23.06% | -94.38% | -94.86% | -93.42% |
| Asset Growth | -8.58% | -6.75% | -21.67% | -20.57% | -47.34% |
| Book Value per Share Growth | -39.54% | -36.98% | +0.00% | +0.00% | +0.00% |
| Debt Growth | -11.05% | -6.73% | -11.88% | +1.09% | +4.39% |
| R&D Expense Growth | -100.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| SG&A Expenses Growth | +7.84% | -3.20% | -0.77% | -2.38% | -45.54% |